On May 16, 2023, Stellantis, Michelin and Faurecia signed a joint venture agreement allowing Stellantis to acquire 33.3% stake in Symbio, a leader in zero-emission hydrogen mobility. Faurecia and Michelin remained shareholders with 33.3% holding each. The transaction is regarded as a significant step in the decarbonization of the mobility industry.
Chabrier assisted Bird&Bird acting for the car manufacturer in connection with the R&D facilities located in Switzerland. The team included Manuel Bianchi della Porta (Partner, M&A) and Daima Vuilleumier (Associate, M&A).